Dimethylformamide → 4-Chloro-6-methoxy-7-((1-methylpiperidin-4-yl)methoxy)quinazoline

HRID 855719Notes

Reaction equation

HRID 855719 reaction equation
[CH3:1][O:2][C:3]1[CH:4]=[C:5]2[C:10](=[CH:11][C:12]=1[O:13][CH2:14][CH:15]1[CH2:20][CH2:19][N:18]([CH3:21])[CH2:17][CH2:16]1)[N:9]=[CH:8][NH:7][C:6]2=O.CN(C=O)C.S(Cl)([Cl:30])=O>>[Cl:30][C:6]1[C:5]2[C:10](=[CH:11][C:12]([O:13][CH2:14][CH:15]3[CH2:20][CH2:19][N:18]([CH3:21])[CH2:17][CH2:16]3)=[C:3]([O:2][CH3:1])[CH:4]=2)[N:9]=[CH:8][N:7]=1

Participants

4

Conditions

Temperature
85 °C

Procedure

A solution of 6-methoxy-7-((1-methylpiperidin-4-yl)methoxy)-3,4-dihydroquinazolin-4-one (2.8 g, 9.24 mmol) in thionyl chloride (28 ml) containing DMF (280 μl) was refluxed at 85° C. for 1 hour. After cooling, the volatiles were removed by evaporation. The precipitate was triturated with ether, filtered, washed with ether and dried under vacuum. The solid was dissolved in methylene chloride and saturated aqueous sodium hydrogen carbonate was added. The organic layer was separated, washed with water, brine, dried (MgSO4) and evaporated to give 4-chloro-6-methoxy-7-((1-methylpiperidin-4-yl)methoxy)quinazoline (2.9 g, 98%).

Workup

  1. temperatureAfter cooling
  2. customthe volatiles were removed by evaporation
  3. customThe precipitate was triturated with ether
  4. filtrationfiltered
  5. washwashed with ether
  6. customdried under vacuum
  7. dissolutionThe solid was dissolved in methylene chloride
  8. additionsaturated aqueous sodium hydrogen carbonate was added
  9. customThe organic layer was separated
  10. washwashed with water, brine
  11. dry with materialdried (MgSO4)
  12. customevaporated

Sources & evidence

ORD record
ord-92bdd4a7c1294d5fb88bd53a01704585
Source dataset
uspto-grants-2007_08
Patent number
US07262201B1

Reaction notes

Loading…